Your email has been successfully added to our mailing list.

×
-0.0205882352941176 -0.0205882352941176 -0.0205882352941176 0.0382450980392157 0.0401960784313727 0.0745098039215688 0.0235294117647061 0.0357843137254904
Stock impact report

Prevail Therapeutics Reports Second Quarter 2019 Financial Results and Recent Business Highlights

Prevail Therapeutics Inc. (PRVL)  More Company Research Source: GlobeNewswire
Last prevail therapeutics inc. earnings: 11/12 09:30 am Check Earnings Report
PDF IND Active for Phase 1/2 Trial of PR001 to Treat Parkinson’s Disease Patients with GBA1 Mutations Successful $125.0 Million Initial Public Offering Completed to Support Program Advancement and Expansion NEW YORK, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (NASDAQ: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative disorders, today reported financial results for the second quarter ended June 30, 2019 and provided an update on recent business highlights. “Since Prevail’s inception in 2017, we have made rapid progress toward our goal of bringing urgently needed therapies to patients with Parkinson’s disease and other neurodegenerative disorders. With the first IND active for our lead gene therapy program, PR001, in Parkinson’s disease with a GBA1 mutation, we are one step closer to our goal, and remain focused on initiating a Phase 1/2 clinical trial of PR001 before the end of th [Read more]
Impact snapshot Event time: PRVL
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
PRVL alerts
from News Quantified
Opt-in for
PRVL alerts

from News Quantified
Opt-in for
PRVL alerts

from News Quantified